Annual SG&A
$232.60 M
+$82.30 M+54.76%
31 December 2023
Summary:
Ionis Pharmaceuticals annual selling, general & administrative expenses is currently $232.60 million, with the most recent change of +$82.30 million (+54.76%) on 31 December 2023. During the last 3 years, it has fallen by -$99.60 million (-29.98%). IONS annual SG&A is now -29.98% below its all-time high of $332.20 million, reached on 31 December 2020.IONS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$61.60 M
-$3.51 M-5.40%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly selling, general & administrative expenses is currently $61.60 million, with the most recent change of -$3.51 million (-5.40%) on 30 September 2024. Over the past year, it has dropped by -$8.40 million (-12.00%). IONS quarterly SG&A is now -47.22% below its all-time high of $116.70 million, reached on 31 December 2020.IONS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$7.89 B
-$358.81 M-4.77%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM selling, general & administrative expenses is currently -$7.89 billion, with the most recent change of -$358.81 million (-4.77%) on 30 September 2024. Over the past year, it has dropped by -$8.09 billion (-3862.71%). IONS TTM SG&A is now -109414.76% below its all-time high of $332.12 million, reached on 31 December 2020.IONS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.8% | -12.0% | -3862.7% |
| 3 y3 years | -30.0% | +104.7% | -3266.7% |
| 5 y5 years | -4.9% | +2.6% | -3026.6% |
IONS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -30.0% | +54.8% | -13.2% | +104.7% | -56.5% | at low |
| 5 y | 5 years | -30.0% | +54.8% | -47.2% | +104.7% | -139.7% | at low |
| alltime | all time | -30.0% | >+9999.0% | -47.2% | +436.6% | <-9999.0% | at low |
Ionis Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $61.60 M(-5.4%) | $250.36 M(-3.2%) |
| June 2024 | - | $65.11 M(+23.7%) | $258.76 M(+7.9%) |
| Mar 2024 | - | $52.64 M(-25.9%) | $239.79 M(+3.1%) |
| Dec 2023 | $232.60 M(+54.8%) | $71.00 M(+1.4%) | $232.66 M(+11.0%) |
| Sept 2023 | - | $70.00 M(+51.7%) | $209.56 M(+20.5%) |
| June 2023 | - | $46.14 M(+1.4%) | $173.96 M(+7.6%) |
| Mar 2023 | - | $45.52 M(-5.0%) | $161.62 M(+7.6%) |
| Dec 2022 | $150.30 M(-12.1%) | $47.90 M(+39.2%) | $150.23 M(+6.6%) |
| Sept 2022 | - | $34.40 M(+1.8%) | $140.93 M(+3.1%) |
| June 2022 | - | $33.80 M(-1.0%) | $136.63 M(-7.6%) |
| Mar 2022 | - | $34.13 M(-11.6%) | $147.93 M(-13.4%) |
| Dec 2021 | $170.90 M(-48.6%) | $38.60 M(+28.2%) | $170.90 M(-31.4%) |
| Sept 2021 | - | $30.10 M(-33.3%) | $249.00 M(-13.3%) |
| June 2021 | - | $45.10 M(-21.0%) | $287.30 M(-8.6%) |
| Mar 2021 | - | $57.10 M(-51.1%) | $314.21 M(-5.4%) |
| Dec 2020 | $332.20 M(+15.9%) | $116.70 M(+70.6%) | $332.12 M(+11.2%) |
| Sept 2020 | - | $68.40 M(-5.0%) | $298.69 M(+2.9%) |
| June 2020 | - | $72.02 M(-4.0%) | $290.33 M(-1.1%) |
| Mar 2020 | - | $75.00 M(-9.9%) | $293.42 M(+2.4%) |
| Dec 2019 | $286.64 M(+17.2%) | $83.28 M(+38.7%) | $286.64 M(+6.4%) |
| Sept 2019 | - | $60.04 M(-20.1%) | $269.43 M(-3.1%) |
| June 2019 | - | $75.11 M(+10.1%) | $278.10 M(+3.3%) |
| Mar 2019 | - | $68.22 M(+3.3%) | $269.19 M(+10.0%) |
| Dec 2018 | $244.62 M(+125.5%) | $66.06 M(-3.9%) | $244.62 M(+9.1%) |
| Sept 2018 | - | $68.71 M(+3.8%) | $224.27 M(+23.0%) |
| June 2018 | - | $66.20 M(+51.6%) | $182.34 M(+31.7%) |
| Mar 2018 | - | $43.65 M(-4.5%) | $138.46 M(+27.6%) |
| Dec 2017 | $108.49 M(+123.2%) | $45.71 M(+70.6%) | $108.49 M(+34.2%) |
| Sept 2017 | - | $26.79 M(+20.0%) | $80.82 M(+25.8%) |
| June 2017 | - | $22.32 M(+63.2%) | $64.22 M(+24.1%) |
| Mar 2017 | - | $13.68 M(-24.2%) | $51.73 M(+6.4%) |
| Dec 2016 | $48.62 M(+30.8%) | $18.04 M(+77.1%) | $48.62 M(+11.1%) |
| Sept 2016 | - | $10.19 M(+3.7%) | $43.76 M(+3.4%) |
| June 2016 | - | $9.82 M(-7.0%) | $42.32 M(+5.1%) |
| Mar 2016 | - | $10.56 M(-19.9%) | $40.27 M(+8.3%) |
| Dec 2015 | $37.17 M(+84.6%) | $13.18 M(+50.6%) | $37.17 M(+20.6%) |
| Sept 2015 | - | $8.75 M(+12.6%) | $30.82 M(+16.1%) |
| June 2015 | - | $7.78 M(+4.1%) | $26.54 M(+14.3%) |
| Mar 2015 | - | $7.47 M(+9.4%) | $23.23 M(+15.3%) |
| Dec 2014 | $20.14 M(+35.0%) | $6.83 M(+52.7%) | $20.14 M(+12.0%) |
| Sept 2014 | - | $4.47 M(+0.2%) | $17.99 M(+6.1%) |
| June 2014 | - | $4.46 M(+1.9%) | $16.95 M(+6.8%) |
| Mar 2014 | - | $4.38 M(-6.4%) | $15.88 M(+6.4%) |
| Dec 2013 | $14.92 M(+19.2%) | $4.68 M(+36.4%) | $14.92 M(+10.7%) |
| Sept 2013 | - | $3.43 M(+1.2%) | $13.48 M(+2.5%) |
| June 2013 | - | $3.39 M(-1.0%) | $13.14 M(+1.4%) |
| Mar 2013 | - | $3.42 M(+5.8%) | $12.96 M(+3.6%) |
| Dec 2012 | $12.52 M(-2.1%) | $3.23 M(+4.5%) | $12.52 M(-4.3%) |
| Sept 2012 | - | $3.10 M(-3.5%) | $13.08 M(-0.1%) |
| June 2012 | - | $3.21 M(+7.8%) | $13.09 M(+2.6%) |
| Mar 2012 | - | $2.98 M(-21.7%) | $12.76 M(-0.3%) |
| Dec 2011 | $12.79 M(+9.6%) | $3.80 M(+22.4%) | $12.79 M(+7.2%) |
| Sept 2011 | - | $3.10 M(+8.0%) | $11.93 M(+2.1%) |
| June 2011 | - | $2.87 M(-4.5%) | $11.68 M(-1.5%) |
| Mar 2011 | - | $3.01 M(+2.2%) | $11.86 M(+1.6%) |
| Dec 2010 | $11.67 M(-19.6%) | $2.94 M(+3.2%) | $11.67 M(-7.0%) |
| Sept 2010 | - | $2.85 M(-6.4%) | $12.55 M(-3.7%) |
| June 2010 | - | $3.05 M(+8.2%) | $13.04 M(-4.6%) |
| Mar 2010 | - | $2.82 M(-26.4%) | $13.66 M(-5.9%) |
| Dec 2009 | $14.52 M(+5.1%) | $3.83 M(+14.8%) | $14.52 M(-3.7%) |
| Sept 2009 | - | $3.33 M(-9.2%) | $15.07 M(+0.5%) |
| June 2009 | - | $3.67 M(-0.1%) | $15.00 M(+2.3%) |
| Mar 2009 | - | $3.68 M(-16.1%) | $14.66 M(+6.1%) |
| Dec 2008 | $13.81 M(+5.8%) | $4.38 M(+34.3%) | $13.81 M(+17.9%) |
| Sept 2008 | - | $3.26 M(-2.1%) | $11.72 M(-8.0%) |
| June 2008 | - | $3.33 M(+17.8%) | $12.73 M(+2.0%) |
| Mar 2008 | - | $2.83 M(+23.6%) | $12.49 M(-4.4%) |
| Dec 2007 | $13.06 M | $2.29 M(-46.5%) | $13.06 M(-5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2007 | - | $4.28 M(+38.5%) | $13.87 M(+11.7%) |
| June 2007 | - | $3.09 M(-9.2%) | $12.42 M(+3.1%) |
| Mar 2007 | - | $3.40 M(+9.6%) | $12.04 M(+7.5%) |
| Dec 2006 | $11.20 M(+42.0%) | $3.10 M(+9.9%) | $11.20 M(+3.4%) |
| Sept 2006 | - | $2.82 M(+4.2%) | $10.83 M(+11.1%) |
| June 2006 | - | $2.71 M(+5.6%) | $9.74 M(+8.9%) |
| Mar 2006 | - | $2.57 M(-6.0%) | $8.95 M(+13.5%) |
| Dec 2005 | $7.89 M(-17.6%) | $2.73 M(+57.0%) | $7.89 M(-1.3%) |
| Sept 2005 | - | $1.74 M(-9.2%) | $7.99 M(-2.1%) |
| June 2005 | - | $1.92 M(+27.3%) | $8.16 M(+51.4%) |
| Mar 2005 | - | $1.50 M(-46.9%) | $5.39 M(-43.7%) |
| Dec 2004 | $9.58 M(-6.1%) | $2.83 M(+48.5%) | $9.58 M(+8.7%) |
| Sept 2004 | - | $1.91 M(-323.6%) | $8.81 M(-10.6%) |
| June 2004 | - | -$853.00 K(-115.0%) | $9.85 M(-25.7%) |
| Mar 2004 | - | $5.69 M(+175.6%) | $13.26 M(+30.0%) |
| Dec 2003 | $10.20 M(+84.0%) | $2.06 M(-30.0%) | $10.20 M(+4.3%) |
| Sept 2003 | - | $2.95 M(+15.5%) | $9.78 M(+6.7%) |
| June 2003 | - | $2.55 M(-2.9%) | $9.16 M(+22.5%) |
| Mar 2003 | - | $2.63 M(+60.3%) | $7.48 M(+34.9%) |
| Dec 2002 | $5.54 M(-64.5%) | $1.64 M(-29.8%) | $5.54 M(-35.2%) |
| Sept 2002 | - | $2.34 M(+168.9%) | $8.56 M(-17.2%) |
| June 2002 | - | $870.00 K(+25.4%) | $10.33 M(-24.0%) |
| Mar 2002 | - | $694.00 K(-85.1%) | $13.60 M(-13.0%) |
| Dec 2001 | $15.63 M(+69.4%) | $4.65 M(+13.1%) | $15.63 M(+12.5%) |
| Sept 2001 | - | $4.12 M(-0.4%) | $13.90 M(+17.2%) |
| June 2001 | - | $4.13 M(+51.2%) | $11.86 M(+16.9%) |
| Mar 2001 | - | $2.73 M(-6.4%) | $10.14 M(+9.8%) |
| Dec 2000 | $9.23 M(-12.9%) | $2.92 M(+40.9%) | $9.23 M(+3.6%) |
| Sept 2000 | - | $2.07 M(-14.1%) | $8.91 M(-3.5%) |
| June 2000 | - | $2.41 M(+32.3%) | $9.24 M(-4.0%) |
| Mar 2000 | - | $1.82 M(-29.8%) | $9.62 M(-9.2%) |
| Dec 1999 | $10.60 M(+11.6%) | $2.60 M(+8.3%) | $10.60 M(-4.5%) |
| Sept 1999 | - | $2.40 M(-14.3%) | $11.10 M(+0.9%) |
| June 1999 | - | $2.80 M(0.0%) | $11.00 M(+4.8%) |
| Mar 1999 | - | $2.80 M(-9.7%) | $10.50 M(+9.4%) |
| Dec 1998 | $9.50 M(+17.3%) | $3.10 M(+34.8%) | $9.60 M(+6.7%) |
| Sept 1998 | - | $2.30 M(0.0%) | $9.00 M(+5.9%) |
| June 1998 | - | $2.30 M(+21.1%) | $8.50 M(+2.4%) |
| Mar 1998 | - | $1.90 M(-24.0%) | $8.30 M(+2.5%) |
| Dec 1997 | $8.10 M(-84.4%) | $2.50 M(+38.9%) | $8.10 M(-84.7%) |
| Sept 1997 | - | $1.80 M(-14.3%) | $52.80 M(+0.4%) |
| June 1997 | - | $2.10 M(+23.5%) | $52.60 M(+1.0%) |
| Mar 1997 | - | $1.70 M(-96.4%) | $52.10 M(+0.6%) |
| Dec 1996 | $51.80 M(+859.3%) | $47.20 M(+2850.0%) | $51.80 M(+763.3%) |
| Sept 1996 | - | $1.60 M(0.0%) | $6.00 M(+5.3%) |
| June 1996 | - | $1.60 M(+14.3%) | $5.70 M(+3.6%) |
| Mar 1996 | - | $1.40 M(0.0%) | $5.50 M(+3.8%) |
| Dec 1995 | $5.40 M(-10.0%) | $1.40 M(+7.7%) | $5.30 M(-3.6%) |
| Sept 1995 | - | $1.30 M(-7.1%) | $5.50 M(-3.5%) |
| June 1995 | - | $1.40 M(+16.7%) | $5.70 M(-1.7%) |
| Mar 1995 | - | $1.20 M(-25.0%) | $5.80 M(-1.7%) |
| Dec 1994 | $6.00 M(+25.0%) | $1.60 M(+6.7%) | $5.90 M(-142.1%) |
| Sept 1994 | - | $1.50 M(0.0%) | -$14.00 M(+79.5%) |
| June 1994 | - | $1.50 M(+15.4%) | -$7.80 M(+420.0%) |
| Mar 1994 | - | $1.30 M(-107.1%) | -$1.50 M(-130.0%) |
| Dec 1993 | $4.80 M(-84.2%) | -$18.30 M(-337.7%) | $5.00 M(-89.8%) |
| Sept 1993 | - | $7.70 M(-1.3%) | $48.90 M(+14.8%) |
| June 1993 | - | $7.80 M(0.0%) | $42.60 M(+17.4%) |
| Mar 1993 | - | $7.80 M(-69.5%) | $36.30 M(+20.2%) |
| Dec 1992 | $30.30 M(+588.6%) | $25.60 M(+1728.6%) | $30.20 M(+395.1%) |
| Sept 1992 | - | $1.40 M(-6.7%) | $6.10 M(+7.0%) |
| June 1992 | - | $1.50 M(-11.8%) | $5.70 M(-28.7%) |
| Mar 1992 | - | $1.70 M(+13.3%) | $8.00 M(+12.7%) |
| Dec 1991 | $4.40 M(+158.8%) | $1.50 M(+50.0%) | $7.10 M(+26.8%) |
| Sept 1991 | - | $1.00 M(-73.7%) | $5.60 M(+21.7%) |
| June 1991 | - | $3.80 M(+375.0%) | $4.60 M(+475.0%) |
| Mar 1991 | - | $800.00 K | $800.00 K |
| Dec 1990 | $1.70 M | - | - |
FAQ
- What is Ionis Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual SG&A year-on-year change?
- What is Ionis Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly SG&A year-on-year change?
- What is Ionis Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM SG&A year-on-year change?
What is Ionis Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of IONS is $232.60 M
What is the all time high annual SG&A for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual selling, general & administrative expenses is $332.20 M
What is Ionis Pharmaceuticals annual SG&A year-on-year change?
Over the past year, IONS annual selling, general & administrative expenses has changed by +$82.30 M (+54.76%)
What is Ionis Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of IONS is $61.60 M
What is the all time high quarterly SG&A for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $116.70 M
What is Ionis Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, IONS quarterly selling, general & administrative expenses has changed by -$8.40 M (-12.00%)
What is Ionis Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of IONS is -$7.89 B
What is the all time high TTM SG&A for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM selling, general & administrative expenses is $332.12 M
What is Ionis Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, IONS TTM selling, general & administrative expenses has changed by -$8.09 B (-3862.71%)